Deal overview
| Target | BTG PLC |
|---|---|
| Bidder | BOSTON SCIENTIFIC CORPORATION |
| Price | £0.00 Full version or £25.00 Light version |
| Publication Date | Nov 20, 2018 |
| Abstract | On 20 November 2018, the US-listed medical devices manufacturer Boston Scientific Corporation ("Boston Scientific") announced that its subsidiary Bravo Bidco Limited ("Bravo Bidco") would make a recommended cash offer, by means of a scheme of arrangement, for the quoted UK-based specialist healthcare company BTG Plc ("BTG"). The offer of 840 pence per share valued the entire ... |
| Number of pages (Full version) | 0 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2024 M&A Monitor Limited
